Sort
15,273 grants matching “antimicrobial resistance”
Pharmacokinetics and immunodynamics of multimodal nanoparticles for HIV and TB
$119,000Jessica L Reynolds · State University Of New York At Buffalo · R56 · FY2014 · AI
Automatic and accurate identification of aerobic bacteria, anaerobic bacteria, yeasts, and fungi in clinical samples derived from animals and from feed for pets
$118,940Guillermo Roberto Risatti · University Of Connecticut Storrs · U18 · FY2021 · FD
NATURAL SUBSTRATES AND INHIBITORS OF MICROBIAL MDR PUMPS
$118,875Northeastern University · R01 · FY2002 · GM
Targeting Cell Membrane Adaptation in Multidrug-Resistant Enterococcus faecium
$118,860Cesar Augusto Arias · University Of Texas Hlth Sci Ctr Houston · R21 · FY2016 · AI
Prevention of Catheter-Associated Blood Stream Infections
$118,783David K Warren · Washington University · K23 · FY2007 · AI
Mechanisms of Enterococcal Niche Modulation during Polymicrobial Infection
$118,638Kimberly Ann Kline · Nanyang Technological University · R21 · FY2016 · AI
Metalloenzyme-guided discovery of new RiPP natural products
$118,559Olivia M Manley · Northwestern University At Chicago · K99 · FY2025 · GM
Biomarker Profiles for Early Diagnosis of Sepsis in Neonates
$118,361James P Mapes · Rules-Based Medicine, Inc. · R44 · FY2011 · GM
TRANSMISSION OF ANTIMICROBIAL RESISTANT BACTERIA IN THE ICU
$118,255Henry M Blumberg · Emory University · M01 · FY2006 · RR
Potent antimicrobial peptides from carrion beetles
$118,255Angelika Fath-Goodin · Paratechs Corp. · R43 · FY2009 · AI
Combinatorial approach to develop novel pre-therapeutic agents targeting virulence factors essential to clinically relevant pathogens
$118,224Hanh Ngoc Lam · University Of California Santa Cruz · K99 · FY2019 · AI
Combinatorial approach to develop novel pre-therapeutic agents targeting virulence factors essential to clinically relevant pathogens
$118,224Hanh Ngoc Lam · University Of California Santa Cruz · K99 · FY2020 · AI
EAGER: BACTERIOPHAGE -NANOMATERIAL INTERACTIONS IN THE ENVIRONMENT- A TOTALLY UNEXPLORED RESEARCH AREA
$118,095Ramesh K Goel · University Of Utah · · FY2016 · ENG
Harnessing bacteriophages as natural predators to combat the superbugs: a pulmonary drug delivery approach
$118,043Kim Chan · University Of Sydney · R21 · FY2016 · AI
Effect of antimicrobial nanoemulsions on oral biofilms
$118,002Valerie A Lee · University Of Texas Hlth Science Center · K08 · FY2008 · DE
Molecular pathways involved in TLR11 mediated IL-12 production by dendritic cells
$117,750Felix Yarovinsky · Ut Southwestern Medical Center · R21 · FY2009 · AI
Novel Biofilm Assay for High Throughput Microbiology Research
$117,700Cristian Ionescu-Zanetti · Fluxion Biosciences, Inc. · R43 · FY2008 · GM
POTENTIALLY BIOACTIVE METABOLITES FROM TROPICAL FUNGI
$117,599Anastacio Emiliano · University Of Puerto Rico · P20 · FY2009 · RR
SYNTHESIS & PHARMACOLOGICAL EVAL OF POTENTIAL ANTI-CANCER & ANTI MICROBIAL AGENT
$117,288John S. Cooperwood · Florida Agricultural And Mechanical Univ · G12 · FY2009 · RR
STRUCTURAL ANALYSIS OF SIDEROPHORE BIOSYNTHESIS: AIDS ANTIBIOTICS
$117,282Audrey L Lamb · University Of Kansas Lawrence · P20 · FY2008 · RR
Biofilm development and Eye Infections
$117,240Amulet Pharmaceuticals, Inc. · R43 · FY2005 · EY
Mechanisms of Action of Non-Coding RNA Molecules
$117,097Joseph E Wedekind · University Of Rochester · R01 · FY2016 · GM
Defining Stat3 Antimicrobial Mechanisms in Human Urothelium
$117,000Christina B Ching · Research Inst Nationwide Children'S Hosp · R03 · FY2025 · DK
Horizontal Genetic Transfer In Staphylococci
$116,920Ashley Robinson · University Of Mississippi Med Ctr · R01 · FY2009 · GM
Collaborative Research: Linking Pharmacokinetics to Epidemiological Models of Vector-Borne Diseases and Drug Resistance Prevention
$116,843Angela Peace · Texas Tech University · · FY2018 · MPS